Recent Articles from Investor Brand Network

Frontieras was featured in a recent article that discussed efforts to position its proprietary FASForm(TM) technology to unlock greater economic value from coal by converting a single feedstock into multiple commercial products—including diesel, jet fuel, naphtha, hydrogen, purified industrial carbon and fertilizer inputs—through a closed-loop, non-combustion process. Rather than relying on emerging sectors, the company targets established global industries collectively valued at more than $2.1 trillion, using existing infrastructure, supply chains and commodity markets. With construction underway on its first commercial-scale facility in West Virginia, designed to process approximately 7,500 tons of coal per day, Frontieras aims to demonstrate a scalable business model that transforms coal into diversified industrial products serving transportation, manufacturing, agriculture and energy markets.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO) is a precision cardiovascular medicine company leveraging epigenetics, genetics and artificial intelligence. The company discussed innovative approaches to cardiovascular disease prevention, risk assessment and cost management at multiple national benefits conferences this month. Cardio’s presentations highlight how advanced cardiovascular risk assessment and detection tools can support both improved health outcomes and more effective healthcare cost management.

MindWave Innovations (NYSE American: APUS) is focused on providing institutional-grade treasury infrastructure for the evolving digital asset economy. “The company aims to help corporations and institutional investors securely hold, manage, and generate yield on Bitcoin reserves. Rather than offering a single product, MindWave has built an integrated ecosystem designed to connect digital asset treasury management, blockchain infrastructure, AI-powered analytics and decentralized financial services,” reads a recent article.

After nearly a decade focused on large language models (LLMs), computer scientist Louis Castricato concluded that the field had reached a stage where groundbreaking advances were becoming harder to find.

Market Street Capital is a boutique capital markets and financial advisory firm that works with established middle-market businesses navigating pivotal moments in their development. The company serves founder-led, family-owned, and private equity-backed enterprises seeking guidance on strategic transactions, capital formation, governance matters, and long-term value creation.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO) is a precision cardiovascular medicine company leveraging epigenetics, genetics and artificial intelligence. The company discussed innovative approaches to cardiovascular disease prevention, risk assessment and cost management at multiple national benefits conferences this month. Cardio’s presentations highlight how advanced cardiovascular risk assessment and detection tools can support both improved health outcomes and more effective healthcare cost management.

RoboStrategy (NASDAQ: BOT) announced the completion of a series of private share issuances to institutional investors conducted between June 26 and June 29, 2026. The registered closed-end fund issued 1,346,668 shares of common stock at a weighted average price of $25.17 per share, generating gross proceeds of approximately $33.9 million before offering expenses.

Xeriant (OTCQB: XERI) announced the publication of an updated 36-page white paper examining global plastic and fiber waste, increasing natural disaster risks and the need for resilient, sustainable construction materials. The paper highlights the company’s NexBoard(TM) building panel and newly introduced NexPatch(TM) fire-resistant joint compound as technologies designed to convert waste into high-performance building materials while supporting safer and more affordable housing.

Aeluma (NASDAQ: ALMU) established a $50 million at-the-market (“ATM”) equity program under a sales agreement led by Roth Capital Partners, allowing the company to sell shares of its common stock from time to time. The company said proceeds, if and when received, are expected to be used for general corporate purposes, including working capital and other liquidity needs.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, has filed an additional patent application as it advances the development of its Texatron(TM) Fusion Engine(TM) platform, marking another step in the company’s effort to build a portfolio of proprietary technologies around future fusion energy systems ( https://nnw.fm/KvNoB ).

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Cardiac monitoring is evolving beyond the routine detection of abnormal heart rhythms toward a future where patients and physicians receive timely actionable insights that can guide clinical decisions outside of a healthcare facility. As healthcare increasingly emphasizes earlier intervention and more personalized care, HeartBeam (NASDAQ: BEAT) is developing technologies designed to transform where and how cardiac data are captured, analyzed and shared, including its proprietary, FDA-cleared HeartBeam System, the first portable, cable-free ECG system capable of synthesizing a 12-lead ECG for assessment of arrhythmias.

SS Innovations International (NASDAQ: SSII) announced it has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, which recognizes a company demonstrating excellence in innovation, commercial success, industry leadership and positive societal impact. The company said the award reflects growing adoption of its SSi Mantra surgical robotic system, which it believes is gaining traction for its advanced technology, user-friendly design, training capabilities and cost efficiency.

As Trump campaigned to win office for this term that he is currently serving, Silicon Valley was fully behind him because he vowed to let the tech industry innovate freely without the “cumbersome” regulatory approach that Biden’s administration had started on. However, recent developments have sent the industry reeling as Trump’s constantly changing positions on AI have left the industry worried about the future.

Researchers at University of Washington have discovered that a drug that is currently approved by the FDA could help in boosting the efficacy of immunotherapy against a rare type of liver cancer that has previously been unresponsive to checkpoint inhibitors.

A new study has revealed that a sodium-ion battery made by Chinese manufacturer Hina has achieved performance levels that are closer than expected to those of Tesla’s lithium-ion batteries. The findings have attracted attention because sodium-ion technology has long been viewed as a lower-cost alternative that still had a significant gap to close before competing with leading battery technologies.

Gold prices came under significant pressure last week, with futures contracts falling by over 3%. The decline reflects growing investor concerns that the Federal Reserve may keep monetary policy restrictive for longer than previously anticipated, reducing the appeal of precious metals.

Renewable energy development across the developing world is being reshaped by cooperation between China and Gulf nations. The United Arab Emirates supplies capital and leverages diplomatic influence while China provides technological expertise and construction capacity.

The electric vehicle revolution has progressed beyond its initial phase focused on technological specifications. Range capabilities, charging velocity, and acceleration metrics dominated early discussions but today, different purchasing factors shape consumer decisions. Reliability and manufacturer trustworthiness now overshadow performance benchmarks.

Five Democratic Senators have intensified scrutiny of a major foreign investment tied to President Donald Trump’s World Liberty Financial (WLF), formally calling for Congressional hearings and sworn testimony from administration officials.

Nightfood Holdings (OTCQB: NGTF) doing business as TechForce Robotics, announced its inclusion in an AINewsWire editorial examining how the rapid expansion of artificial intelligence infrastructure is creating new opportunities across the semiconductor manufacturing ecosystem. The article highlights the shift of advanced semiconductor manufacturing investment to the United States and the growing demand for companies supporting AI-driven production.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Laboratory and pharmaceutical operations increasingly face the same challenge that has accelerated automation across industries from manufacturing to hospitality: how to improve efficiency while freeing highly trained personnel to focus on higher-value work. Researchers, technicians, and production staff often spend significant time on routine logistics tasks that, while necessary, do not directly advance scientific work, product development, or manufacturing output. As labor costs rise and productivity demands grow, pharmaceutical and biotechnology organizations are exploring automation solutions capable of supporting operational scalability without disrupting tightly regulated workflows.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) released new consumer research showing a significant gap between what shoppers expect from supermarkets and what they believe stores currently deliver. Based on a survey of 1,600 consumers across the United States, France and Italy, the report found that 60% of respondents view fast, hassle-free shopping as highly important, but only 36% believe supermarkets consistently provide that experience. Similar gaps were identified for pricing transparency, timely promotions and rewards, and other digitally influenced shopping expectations.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

HeartBeam (NASDAQ: BEAT) announced it has completed patient enrollment ahead of schedule in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The study enrolled 120 patients presenting with chest pain at two clinical sites in Belgrade, Serbia, with participants evaluated using both a standard 12-lead ECG and the company’s 3D ECG technology. Data analysis is underway, and HeartBeam plans to present the results at a major cardiology conference later this year.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Silo Pharma (NASDAQ: SILO), announced that drug-device development partner Resyca will conduct a robustness study of the microchip-based Soft-Mist Nasal Spray system used to deliver SPC-15, the company’s lead intranasal prophylactic treatment candidate for post-traumatic stress disorder. The study will evaluate device performance consistency and the stability of SPC-15 and placebo formulations over a 30-day period, supporting the combination-a portfolio includes innovative programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Silo’s research is conducted in collaboration with leading universities and laboratories.

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising.

Globavend Holdings (NASDAQ: GVH) announced the debut of its first fully AI-produced original micro drama, “Buried Innocent,” marking its entry into the growing global micro-drama market. Created using the company’s proprietary “Imaginary” AI-powered cinematic production platform, the series showcases an end-to-end generative AI workflow designed to accelerate production, reduce costs and support multilingual global distribution. Globavend also released “Kopi-Kopi,” an original live-action micro drama, with both series available through its proprietary “Loomi: Short Drama” streaming platform and on TikTok.

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Suntex Enterprises (OTC: SNTX) announced the appointment of Vincent Ornelas as an independent director, adding more than a decade of executive technology experience to its board as the company advances its long-term strategy of building a diversified operating business. Ornelas spent nearly 11 years in executive technology roles at SpaceX, supporting leadership during the company’s expansion, including early Starbase development and technology infrastructure for Starlink and xAI initiatives, and currently serves as an executive support engineer at Citadel.

When most people think about their risk for heart disease, they think about family history. Did a parent or grandparent have a heart attack? Is heart disease “in their genes”? It’s an understandable assumption, and genetics does play a role in cardiovascular risk. But a growing body of research suggests that DNA sequence alone tells only part of the story, and increasingly, scientists believe it may be the smaller part. The rest of the story is largely written in epigenetics, a field of biology that examines how genes are switched on or off, turned up or down, without any change to the underlying DNA code itself. Cardio Diagnostics Holdings (NASDAQ: CDIO), a medical technology company built around epigenetics-based cardiovascular testing, has positioned this science at the center of its diagnostic platform.

Oncotelic Therapeutics (OTCQB: OTLC), together with Sapu Nano, announced the publication of a peer-reviewed manuscript in the International Journal of Molecular Sciences validating its proprietary Deciparticle(TM) nanoparticle platform through the development of Sapu003, an investigational intravenous everolimus formulation currently being evaluated in an ongoing Phase 1b clinical trial. The publication details the platform’s formulation design, scalable cGMP manufacturing process, product stability and preclinical performance, while demonstrating its potential to enable intravenous delivery of poorly water-soluble therapeutic compounds.

Swarmer (NASDAQ: SWMR) announced an amendment to its May 2026 software licensing agreement that increases the total contract value to $3.87 million and is expected to generate an additional $1.02 million in revenue. Under the revised agreement, Czech-based Progress TRW S.R.O. will purchase $1.41 million in SkyKnight software licenses, while Meta Bureau LLC increased its original autonomy software order from $1.38 million to $2.47 million.

Quantum computing advancement has become a defining priority for American national security and technological competitiveness. The Trump administration released executive orders addressing two interconnected objectives: accelerating domestic quantum research and protecting federal computing infrastructure from emerging threats.

Oracle has reduced its global workforce by about 21,000 employees as the company moves more aggressively into artificial intelligence and cloud technology. The decision marks one of the largest workforce reductions in Oracle’s history and reflects the growing impact that AI is having on the technology industry.

Refined copper has enjoyed record prices, but the facilities that smelt the concentrate are struggling to stay afloat because processing fees have tanked to extremely low levels. Processors now have to depend on the by-products of the refining process in order to keep their doors open.

AINewsWire Editorial Coverage : A tectonic shift is reshaping global semiconductor manufacturing. Hundreds of billions of dollars in new investment are flowing into the United States, pulling Taiwan’s advanced manufacturing ecosystem closer to North American customers, capital markets and emerging opportunities. As artificial intelligence drives unprecedented demand for semiconductors and data center infrastructure, the companies enabling that production, including the precision engineers, automation providers and specialty materials manufacturers, are beginning to follow. Positioned directly at this intersection is Nightfood Holdings Inc. (OTCQB: NGTF) ( Profile ), doing business as TechForce Robotics, an AI-enhanced robotics and automation company that is actively building its strategic footprint within this migration. TechForce Robotics just announced a strategic alliance with Taiwan-based Jiun Jiang Enterprise Co. Ltd. (JJ Enterprise), a precision engineering and advanced manufacturing company serving the semiconductor, advanced packaging, and industrial automation industries. The partnership is designed to give TechForce Robotics access to decades of expertise in semiconductor-grade manufacturing, advanced materials processing, and high-performance production systems, capabilities central to the ongoing migration reshaping global manufacturing. This move reflects the company’s commitment to becoming a key player among companies focused on providing the hardware and infrastructure that power today’s rapidly expanding AI ecosystem, including NVIDIA Corporation (NASDAQ: NVDA), Advanced Micro Devices Inc. (NASDAQ: AMD), Broadcom Inc. (NASDAQ: AVGO) and…

Nightfood Holdings (OTCQB: NGTF), through its TechForce Robotics subsidiary, is positioning itself to capitalize on the ongoing migration of Taiwan’s semiconductor supply chain to the United States through a strategic alliance with Taiwan-based Jiun Jiang Enterprise Co. Ltd. The partnership provides TechForce Robotics with access to semiconductor-grade manufacturing expertise in advanced packaging, thermal management and industrial automation, strengthening its position in markets supporting AI infrastructure, advanced semiconductor production and next-generation manufacturing.

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies to aid in cardiac and other surgeries, including telesurgeries, reported record first-quarter 2026 financial results, highlighting accelerating commercial adoption of its SSi Mantra surgical robotic platform as the company continues expanding internationally and pursuing regulatory approvals in major healthcare markets.

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.

This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.

Tonix Pharmaceuticals (NASDAQ: TNXP) announced the first patient has been enrolled in the HORIZON Phase 2 trial evaluating TNX-102 SL 5.6 mg as a first-line monotherapy for adults with major depressive disorder (MDD). The randomized, double-blind, placebo-controlled study is expected to enroll approximately 360 patients at about 30 U.S. sites and will assess changes in depression severity after six weeks of treatment, along with measures of sleep quality, anxiety and global clinical improvement.

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.

HealthLynked (OTCQB: HLYK) announced the launch of its next-generation AI Agent Platform, a conversational voice AI solution designed to automate patient scheduling, care coordination and healthcare communications for both patients and providers. The platform supports inbound and outbound voice interactions, enabling AI agents to schedule appointments, navigate physician office phone systems, collect patient and insurance information, perform intake functions, confirm appointments and provide 24/7 answering services for healthcare practices.

Xlife Sciences (SIX: XLS) announced that shareholders approved all proposals presented at the company’s Annual General Meeting, where 3,134,367 voting shares, representing 54.3% of the total share capital, were represented. Chairman David L. Deck said the company strengthened its portfolio during the past year and highlighted the Nasdaq listing of portfolio company Veraxa Biotech (NASDAQ: VRXA) and the planned Landsteiner Scientific platform as key milestones supporting the next phase of growth.

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Disseminated on behalf of CMX Gold & Silver Corp. (CSE: CXC) (OTC: CXXMF) and may include paid advertising.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume. Cardio Diagnostics Holdings (NASDAQ: CDIO) reports that approximately 50% of individuals with coronary heart disease do not present with traditional risk factors and conventional risk calculators have an average sensitivity of 39%. In practical terms, that means that many who “look healthy” go on to have CHD and preventable cardiac events such as a heart attack.

The digital asset industry is entering a new phase of development. While early blockchain adoption was largely driven by speculation and asset appreciation, today’s market is increasingly focused on building sustainable financial infrastructure capable of supporting long-term institutional participation. Companies that can facilitate this transition are beginning to occupy an increasingly important role within the evolving digital asset ecosystem.

BioAdaptives (OTC: BDPT) announced that MyndRenew(TM), the nighttime component of its MyndSystem(TM) cognitive health platform, has received TruShield Certified status, confirming compliance with anti-doping standards established by the World Anti-Doping Agency and the UFC. Combined with the previously certified MyndMed(TM) daytime formula, the company said MyndSystem(TM) is now a fully WADA-compliant 24/7 cognitive performance and recovery system for professional athletes.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

LIXTE Biotechnology (NASDAQ: LIXT) announced it has been added to the Russell Microcap(R) Index, effective after the close of U.S. markets on June 26, 2026, with the reconstituted index taking effect at the opening of trading on June 29, 2026. The company said inclusion in the widely followed benchmark is expected to increase its visibility among institutional investors and investment products that track Russell indexes.

Suntex Enterprises (OTC: SNTX) announced the completion of several strategic initiatives over the past two weeks, including fulfilling commitments under its asset purchase agreement with Golden Triangle Ventures, engaging a PCAOB-registered accounting firm to begin the audit process, appointing independent director Lisa Surnow and advancing plans to qualify for the OTCQB(R) Venture Market, subject to meeting applicable listing and regulatory requirements. The company also reported continued progress on its 100-acre mixed-use South Texas development and expansion of its commercial construction business through subsidiary JA Development & Construction.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

Gold prices edged higher at the start of the week, supported by easing concerns in energy markets after early signs of progress emerged from discussions between the United States and Iran. This followed a tentative agreement to reopen the Strait of Hormuz, which helped calm fears of supply disruptions, while diplomatic efforts led by France saw President Trump endorse a framework aimed at reducing tensions and advancing negotiations.

Battery technology improvements and lower manufacturing costs have finally made it possible for European automakers to produce compact electric vehicles at affordable prices . These smaller models fit comfortably on the tight city streets of major European capitals, where larger vehicles struggle.

Alphabet experienced its steepest market setback since 2025 on June 22 as investor concerns surrounding artificial intelligence intensified following the resignation of two key researchers and growing questions about the company’s AI strategy.

According to recent data released by CMS actuaries, spending on health care in the U.S. jumped to $5.7tn in 2025, the third consecutive year in which spending growth exceeded 7%. The data shows that one of the key drivers of this spike was pricey medications, such as GLP-1s, medications used to treat obesity.

U.S. tech giant Anthropic has made shocking accusations against Alibaba, a Chinese technology and e-commerce company, of “illicitly” and “brazenly” extracting AI capabilities from Claude, Anthropic’s flagship AI model. The accusations were contained in a letter that the firm sent to Congress.

A new report from Aurora Energy Research finds that stronger European grid connections could unlock an extra 27TWh of clean power while reducing pollution via grid upgrades . The study, titled “Europe’s Energy Trilemma Rewired,” examines how grid investment could help address Europe’s three central energy priorities: cutting greenhouse gas emissions, securing energy supply chains, and managing costs.

Money in the crypto market often moves in patterns that can look dramatic at first glance. Recently, ETF flow data has created a strong narrative that money may be shifting from Bitcoin to XRP. But while there is some truth to this idea, the full picture is more balanced and less extreme than it sounds.

Safe Pro Group (NASDAQ: SPAI), a mission-driven tech company that develops AI-powered security and defense solutions, recently announced that it has rapidly delivered against a U.S. Army order for Threat Analysis Kits under an award valued at around $742,000 ( https://ibn.fm/smCGt ).

This article has been disseminated on behalf of ComprehensiveHealthcare Systems Inc. and may include paid advertising.